|
$1,091,016
|
To analyze obstacles and propose solutions to make medicines more affordable and accessible, drive greater competition and transparency in biologics, expose anticompetitive behaviors nad map the role of trade secrecy as a barrier to biosimilars.
|
2021 - 2023
|
LJAF
|
|
$1,081,039
|
To support Grantee's Center for Innovation in its efforts to maximize the access and affordability of life saving drugs while maintaining incentives for innovation.
|
2019 - 2021
|
LJAF
|
|
$652,120
|
To analyze pharmaceutical industry behaviors and their impact on drug prices.
|
2017 - 2020
|
LJAF
|
|
$698,157
|
To analyze policy solutions for addressing consolidation and high health care prices at the state level.
|
2021 - 2023
|
LJAF
|
